COMPARISON OF DEFERASIROX, DEFERIPRONE, AND DESFERRIOXAMINE EFFECTIVENESS ON MYOCARDIAL IRON CONCENTRATIONS AND BIVENTRICULAR FUNCTION BY QUANTITATIVE MR IN BETA-THALASSEMIA MAJOR

被引：0
|
作者：
Pepe, A. [1 ]
Ramazzotti, A. [1 ]
Cianciulli, P. [2 ]
Spasiano, A. [3 ]
Capra, M. [4 ]
Borgna-Pignatti, C. [5 ]
Putti, M. C. [6 ]
Lippi, A. [7 ]
Romeo, M. A. [8 ]
Bisconte, M. G. [9 ]
Filosa, A. [10 ]
Caruso, V. [11 ]
Quarta, A. [12 ]
Pitrolo, L. [13 ]
De Sanctis, V. [14 ]
Gerardi, C. [15 ]
Maggio, A. [16 ]
Pietrangelo, A. [17 ]
Rossi, G. [1 ]
Lombardi, M. [1 ]
机构：
[1] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[2] St Eugenio Hosp, Ctr Talassemie, Rome, Italy
[3] Cardarelli Hosp, Ctr Cura Microcitemie, Naples, Italy
[4] G Di Cristina Hosp Arnas, Palermo, Italy
[5] Univ Ferrara, Dept Pediat, I-44100 Ferrara, Italy
[6] Univ Padua, Dept Pediat, Padua, Italy
[7] Meyer Hosp, Ctr Talassemie & Emoglobinopatie, Florence, Italy
[8] Univ Catania, Dept Pediat, Catania, Italy
[9] UO Ematol, Ctr Microcitemia, Cosenza, Italy
[10] Cardarelli Hosp, UOC Pediat, Naples, Italy
[11] Garibaldi Hosp, Ctr Microcitemia, Catania, Italy
[12] A Perrino Hosp, Brindisi, Italy
[13] Villa Sofia CTO Hosp, Palermo, Italy
[14] St Anna Hosp, Pediat Adolescent Unit, Dept Reprod & Growth, Ferrara, Italy
[15] Osped Civile, Ctr Talassemia, Sciacca, Agri Cento, Italy
[16] V Cervello Hosp, Palermo, Italy
[17] Univ Hosp Modena & Reggio Emilia, Ctr Hemochromatosis, Modena Reggio Emilia, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0901
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [1] Comparison of Deferasirox, Deferiprone, and Desferrioxamine Effectiveness on Myocardial Iron Concentrations and Biventricular Function by Quantitative MR in Beta-Thalassemia Major
    Pepe, Alessia
    Favilli, Brunella
    Positano, Vincenzo
    Cianciulli, Paolo
    Spasiano, Anna
    Capra, Marcello
    Borgna-Pipatti, Caterina
    Putti, Maria Caterina
    Casini, Tommaso
    Romeo, Maria Antonietta
    Bisconte, Maria Grazia
    Filosa, Aldo
    Caruso, Vincenzo
    Quarta, Antonella
    Pitrolo, Lorella
    De Sanctis, Vincenzo
    Gerardi, Calogera
    Maggio, Aurelio
    Pietrangelo, Antonello
    Lombardi, Massimo
    BLOOD, 2008, 112 (11) : 1317 - 1318
  • [2] Comparison of deferasirox, deferiprone, and desferrioxamine effectiveness on myocardial iron concentrations and biventricular function by quantitative MR in thalassemia major
    Pepe, A.
    Ramazzotti, A.
    Favilli, B.
    Cianciulli, P.
    Spasiano, A.
    Capra, M.
    Pugliese, F.
    Putti, M. C.
    Rossi, G.
    Lombardi, M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 495 - 495
  • [3] Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
    Pepe, Alessia
    Meloni, Antonella
    Capra, Marcello
    Cianciulli, Paolo
    Prossomariti, Luciano
    Malaventura, Cristina
    Putti, Maria Caterina
    Lippi, Alma
    Romeo, Maria Antonietta
    Bisconte, Maria Grazia
    Filosa, Aldo
    Caruso, Vincenzo
    Quarta, Antonella
    Pitrolo, Lorella
    Missere, Massimiliano
    Midiri, Massimo
    Rossi, Giuseppe
    Positano, Vincenzo
    Lombardi, Massimo
    Maggio, Aurelio
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01): : 41 - 47
  • [4] Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone-Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy
    Pepe, Alessia
    Meloni, Antonella
    Pepe, Pasquale
    Capra, Marcello
    D'Ascola, Domenico Giuseppe
    Santodirocco, Michele
    Cianciulli, Paolo
    Caruso, Vincenzo
    Romeo, Maria Antonietta
    Filosa, Aldo
    Pitrolo, Lorella
    Putti, Maria Caterina
    Maggio, Aurelio
    Missere, Massimiliano
    Positano, Vincenzo
    Lombardi, Massimo
    Ricchi, Paolo
    BLOOD, 2011, 118 (21) : 1379 - 1380
  • [5] Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox
    Economou, Marina
    Printza, Nikoletta
    Teli, Aikaterini
    Tzimouli, Vassiliki
    Tsatra, Ioanna
    Papachristou, Fotis
    Athanassiou-Metaxa, Miranda
    ACTA HAEMATOLOGICA, 2010, 123 (03) : 148 - 152
  • [6] A MRI prospective survey on heart iron and function in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
    Pepe, A.
    Meloni, A.
    Rossi, G.
    Natale, L.
    Valeri, G.
    Salvatori, C.
    Keilberg, P.
    Positano, V.
    Maggio, A.
    Lombardi, M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 965 - 965
  • [7] Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia
    Anderson, LJ
    Wonke, B
    Prescott, E
    Holden, S
    Walker, JM
    Pennell, DJ
    LANCET, 2002, 360 (9332): : 516 - 520
  • [8] Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
    Alavi, Samin
    Sadeghi, Elham
    Ashenagar, Azin
    BLOOD RESEARCH, 2014, 49 (01) : 72 - 73
  • [9] Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
    Daar, S.
    Pathare, A. V.
    ANNALS OF HEMATOLOGY, 2006, 85 (05) : 315 - 319
  • [10] Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
    S. Daar
    A. V. Pathare
    Annals of Hematology, 2006, 85 : 315 - 319
12345